Assessment of in vitro anti-urolithiasis potential of Berberis aristata DC.
DOI:
https://doi.org/10.31783/elsr.2023.92340348Keywords:
aggregation assay, calcium oxalate, simultaneous flow static model, urolithiasisAbstract
Urolithiasis is a highly prevalent and excruciating urological condition characterized by the accumulation of stones within the urinary system's walls. Kidney stones also referred to as nephrolithiasis, urolithiasis, or ureterolithiasis, are classified based on their specific location within the urinary system. Traditional approaches to manage urolithiasis include allopathic medications, surgical interventions, and shockwave lithotripsy, all of which are associated with various side effects. Due to these associated drawbacks, increased focus on exploring natural medicine for both prevention and management of urolithiasis has taken momentum. Anti-urolithiatic activity encompasses the capacity of specific plants and their extracts to prevent or alleviate urolithiasis, commonly known as kidney stones. Throughout various cultures, numerous plants have traditionally been employed as natural interventions to ward off or address kidney stones. One such potential herbal plant for the management of urolithiasis is Berberis aristata (Indian barberry or Tree Turmeric) which is known for its use in the management of urolithiasis in folk medicine. This plant is notably rich in alkaloids, with berberine being the primary alkaloid that contributes to its antioxidant as well as anti-inflammatory effects. In the present in vitro study, aqueous root extract of Berberis aristata (BAE) at varying concentrations, was examined for its effectiveness in preventing the formation of calcium oxalate crystals when introduced alongside the extract. The results revealed the effectiveness of the extract in preventing crystallization, suggesting its potential utility in managing urinary stone formation.
References
[1] C. Korkmaz, D. Ü. Cansu and J. A. Sayer (2017). Urolithiasis as an extraarticular manifestation of ankylosing spondylitis. Rheumatol Int., 37: 1949-1956.
[2] W. Cheungpasitporn, C. Thongprayoon, M. A. Mao, O. A. O'Corragain, P. J. Edmonds and S. B. Erickson (2014). The Risk of Coronary Heart Disease in Patients with Kidney Stones: A Systematic Review and Meta-analysis. N Am J Med Sci., 6: 580-585.
[3] M. López and B. Hoppe (2010). History, epidemiology and regional diversities of urolithiasis. Pediatr Nephrol., 25: 49-59.
[4] X. Qian, J. Wan, J. Xu, C. Liu, M. Zhong, J. Zhang, Y. Zhang, et al. (2022). Epidemiological Trends of Urolithiasis at the Global, Regional, and National Levels: A Population-Based Study. Int J Clin Pract., Article ID 6807203, doi: 10.1155/2022/6807203.
[5] N. H. Sofia, T. M. Walter and T. Sanatorium (2016). Prevalence and risk factors of kidney stone. Glob. J. Res. Anal., 5: 183-187.
[6] S. A. Howles and R. V. Thakker (2020). Genetics of kidney stone disease. Nat Rev Urol., 17: 407-421.
[7] T. Shafi, M. Malhi, P. Hanumanthrao and P. R. Kumari (2023). A update on current diagnostic modalities and treatment of urolithiasis review. J. Surv. Fish. Sci., 10: 710-717.
[8] T. Alelign and B. Petros (2018). Kidney stone disease: an update on current concepts. Adv. Urol., Article ID 3068365, doi: 10.1155/2018/3068365.
[9] S. Ringold, T. J. Glass and R. M. Glass (2005). Kidney stones. J. Am. Med. Assoc., 293: 1158. doi: 10.1001/jama.293.9.1158.
[10] A. Aggarwal, S. Tandon, S. Singla and C. Tandon (2010). Diminution of oxalate induced renal tubular epithelial cell injury and inhibition of calcium oxalate crystallization in vitro by aqueous extract of Tribulus terrestris. Int. Braz. J. Urol., 36: 480-489.
[11] M. S. Parmar (2004). Kidney stones. Br. Med. J., 328: 1420-1424.
[12] J. D. Hernandez, J. S. Ellison and T. S. Lendvay (2015). Current trends, evaluation, and management of pediatric nephrolithiasis. JAMA Pediatr., 169: 964-970.
[13] K. C. Koo, A. Halawani, V. K. Wong, D. Lange and B. H. Chew (2023). Monogenic features of urolithiasis: A comprehensive review. Asian J Urol., doi: 10.1016/j.ajur.2023.03.004.
[14] J. C. Lieske, S. T. Turner, S. N. Edeh, E. B. Ware, S. L. Kardia and J. A. Smith (2016). Heritability of dietary traits that contribute to nephrolithiasis in a cohort of adult sibships. J Nephrol., 29: 45-51.
[15] M. Oswal, R. Varghese, T. Zagade, C. Dhatrak, R. Sharma and D. Kumar (2023). Dietary supplements and medicinal plants in urolithiasis: diet, prevention, and cure. J. Pharm. Pharmacol., 75: 719-745.
[16] M. Rahimi-Madiseh, Z. Lorigoini, H. Zamani-Gharaghoshi and M. Rafieian-Kopaei (2017). Berberis vulgaris: specifications and traditional uses. Iran J Basic Med Sci., 20: 569-587.
[17] H. Andola, R. Rawal, M. S. M. Rawat, I. Bhatt and V. Purohit (2010). Analysis of Berberine content using HPTLC fingerprinting of root and bark of three Himalayan Berberis Species. Asian J. Biotechnol., 2: 239-245.
[18] N. Malkani, M. I. Sohail, F. Ijaz, A. Naeem, S. Mumtaz and Z. Saeed (2022). Berberis aristata reduces vancomycin-induced nephrotoxicity by down-regulation of cell proliferation markers. J Herb Med., 31: 100540. doi: 10.1016/j.hermed.2022.100540.
[19] V. Chander, J. S. Aswal, R. Dobhal and D. P. Uniyal (2017). A review on Pharmacological potential of Berberine; an active component of Himalayan Berberis aristata. J. Phytopharmacol., 6: 53-58.
[20] K. J. Sharmila, S. M. Monisha, A. A. Beevi and V. Deebarathi (2020). Antibacterial, antioxidant, anticancer effects and GCMS analysis of Berberis aristata. Biomedicine, 40: 286-293.
[21] R. Kumar, V. Nair, Y. K. Gupta, S. Singh and S. Arunraja (2016). Berberis aristata ameliorates adjuvant-induced arthritis by inhibition of NF-κB and activating nuclear factor-E2-related factor 2/hem oxygenase (HO)-1 signaling pathway. Immunol Invest., 45: 473-489.
[22] F. Gholampour and S. Keikha (2018). Berberine protects the liver and kidney against functional disorders and histological damages induced by ferrous sulfate. Iran J Basic Med Sci., 21: 476-482.
[23] A. Sreedevi, B. Koganti and K. V. S. R. G. Prasad (2010). Effect of decoction of root bark of Berberis aristata against cisplatin- induced nephrotoxicity in rats. Int. J. Pharm. Sci., 2: 51-56.
[24] P. K. Patel, M. A. Patel, B. A. Vyas, D. R. Shah and T. R. Gandhi (2012). Antiurolithiatic activity of saponin rich fraction from the fruits of Solanum xanthocarpum Schrad. & Wendl.(Solanaceae) against ethylene glycol induced urolithiasis in rats. J Ethnopharmacol., 144: 160-170.
[25] B. Hess, Y. Nakagawa and F. L. Coe (1989). Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am J Physiol., 257: F99-F106.
[26] N. A. M. Farook, G. A. S. Dameem, N. M. I. Alhaji, R. Sathiya, J. Muniyandi, S. Sangeetha and J. Muniyandi (2004). Inhibition of mineralization of urinary stone forming minerals by some hills area fruit juice. E-J. Chem., 1: 137-141.
[27] K. Agarwal and R. Varma (2015). Ethnobotanical study of antilithic plants of Bhopal district. J Ethnopharmacol., 174: 17-24.
[28] N. Lokendrajit, N. Swapana, C. D. Singh and C. B. Singh (2011). Herbal folk medicines used for urinary and calculi/stone cases complaints in Manipur. NeBIO, 2: 1-5.
[29] H. Chandra, D. Patel, P. Kumari, J. S. Jangwan and S. Yadav (2019). Phyto-mediated synthesis of zinc oxide nanoparticles of Berberis aristata: Characterization, antioxidant activity and antibacterial activity with special reference to urinary tract pathogens. Mater. Sci. Eng. C, 102: 212-220.
[30] R. A. Pérez-Hernández, S. G. Treviño-Moreno, G. Arévalo-Martínez, E. Sánchez-García, C. Leos-Rivas and C. Rivas-Morales (2018). Antiurolithic activity of Berberis trifoliate extract on induced urolithiasis in rats by zinc disc implantation. Afr J Tradit Complement Altern Med., 15: 168-173.
[31] S. Bashir, A. H. Gilani, A. A. Siddiqui, S. Pervez, S. R. Khan, N. J. Sarfaraz and A. J. Shah (2010). Berberis vulgaris root bark extract prevents hyperoxaluria-induced urolithiasis in rats. Phytother Res., 24: 1250-1255.
[32] V. Jyothilakshmi, G. Thellamudhu, A. Kumar, A. Khurana, D. Nayak and P. Kalaiselvi (2013). Preliminary investigation on ultra-high diluted B. vulgaris in experimental urolithiasis. Homeopathy, 102: 172-178.
[33] T. Ganesan, D. Bhavani Ravi, J. Vasavan, A. Khurana, D. Nayak and K. Periandavan (2015). Homoeopathic preparation of Berberis vulgaris as an inhibitor of calcium oxalate crystallization: An in vitro evidence. Indian J. Res. Homoeopathy, 9: 152-157.
[34] V. Jyothilakshmi, G. Thellamudhu, R. Chinta, K. Alok, K. Anil, N. Debadatta and P. Kalaiselvi (2014). Beneficial antioxidative effect of the homeopathic preparation of Berberis vulgaris in alleviating oxidative stress in experimental urolithiasis. Forsch Komplementmed, 21: 7-12.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Author (s)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright © The Author(s). This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and source are properly credited, and the work is not modified or adapted.
